Teva Pharmaceutical Industries (TEVA) Competitors $16.58 -0.21 (-1.22%) Closing price 03:59 PM EasternExtended Trading$16.55 -0.02 (-0.15%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TEVA vs. GSK, TAK, ARGX, BNTX, ONC, SMMT, ITCI, GMAB, RDY, and VTRSShould you be buying Teva Pharmaceutical Industries stock or one of its competitors? The main competitors of Teva Pharmaceutical Industries include GSK (GSK), Takeda Pharmaceutical (TAK), argenx (ARGX), BioNTech (BNTX), Beigene (ONC), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), and Viatris (VTRS). These companies are all part of the "pharmaceutical products" industry. Teva Pharmaceutical Industries vs. GSK Takeda Pharmaceutical argenx BioNTech Beigene Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Viatris GSK (NYSE:GSK) and Teva Pharmaceutical Industries (NYSE:TEVA) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment. Does the MarketBeat Community prefer GSK or TEVA? Teva Pharmaceutical Industries received 514 more outperform votes than GSK when rated by MarketBeat users. Likewise, 67.88% of users gave Teva Pharmaceutical Industries an outperform vote while only 57.10% of users gave GSK an outperform vote. CompanyUnderperformOutperformGSKOutperform Votes82457.10% Underperform Votes61942.90% Teva Pharmaceutical IndustriesOutperform Votes133867.88% Underperform Votes63332.12% Does the media refer more to GSK or TEVA? In the previous week, Teva Pharmaceutical Industries had 12 more articles in the media than GSK. MarketBeat recorded 34 mentions for Teva Pharmaceutical Industries and 22 mentions for GSK. Teva Pharmaceutical Industries' average media sentiment score of 1.11 beat GSK's score of 0.83 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GSK 16 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teva Pharmaceutical Industries 21 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Is GSK or TEVA a better dividend stock? GSK pays an annual dividend of $1.68 per share and has a dividend yield of 4.3%. Teva Pharmaceutical Industries pays an annual dividend of $1.0110 per share and has a dividend yield of 6.1%. GSK pays out 86.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Teva Pharmaceutical Industries pays out -87.9% of its earnings in the form of a dividend. Teva Pharmaceutical Industries is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has preferable valuation and earnings, GSK or TEVA? GSK has higher revenue and earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than GSK, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGSK$31.53B2.54$3.29B$1.9419.99Teva Pharmaceutical Industries$16.62B1.14-$1.64B-$1.15-14.53 Which has more risk & volatility, GSK or TEVA? GSK has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, Teva Pharmaceutical Industries has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Do analysts prefer GSK or TEVA? GSK currently has a consensus target price of $40.58, suggesting a potential upside of 4.65%. Teva Pharmaceutical Industries has a consensus target price of $24.43, suggesting a potential upside of 46.24%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher possible upside, analysts clearly believe Teva Pharmaceutical Industries is more favorable than GSK.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GSK 1 Sell rating(s) 8 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 2.42Teva Pharmaceutical Industries 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Is GSK or TEVA more profitable? GSK has a net margin of 8.13% compared to Teva Pharmaceutical Industries' net margin of -9.91%. GSK's return on equity of 48.59% beat Teva Pharmaceutical Industries' return on equity.Company Net Margins Return on Equity Return on Assets GSK8.13% 48.59% 11.11% Teva Pharmaceutical Industries -9.91%42.46%6.65% Do institutionals and insiders have more ownership in GSK or TEVA? 15.7% of GSK shares are held by institutional investors. Comparatively, 54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. 10.0% of GSK shares are held by insiders. Comparatively, 0.5% of Teva Pharmaceutical Industries shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryTeva Pharmaceutical Industries beats GSK on 11 of the 21 factors compared between the two stocks. Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TEVA vs. The Competition Export to ExcelMetricTeva Pharmaceutical IndustriesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$19.00B$6.58B$5.41B$19.60BDividend YieldN/A2.66%5.22%3.84%P/E Ratio-11.569.2126.7734.82Price / Sales1.14257.57395.4435.62Price / Cash5.0565.8538.2517.51Price / Book3.526.576.874.75Net Income-$1.64B$144.25M$3.23B$1.02B7 Day Performance0.09%5.13%5.32%0.03%1 Month Performance25.60%9.67%13.56%11.37%1 Year Performance0.69%-0.88%17.86%4.74% Teva Pharmaceutical Industries Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TEVATeva Pharmaceutical Industries3.2851 of 5 stars$16.58-1.2%$24.43+47.4%-0.4%$18.79B$16.62B-11.4336,800Positive NewsOptions VolumeGSKGSK1.948 of 5 stars$37.34+2.0%$40.58+8.7%-13.9%$77.05B$31.53B23.4990,100Positive NewsTAKTakeda Pharmaceutical3.3278 of 5 stars$14.17-1.4%N/A+7.2%$45.07B$4.58T35.4147,300Positive NewsHigh Trading VolumeARGXargenx3.2924 of 5 stars$560.90+2.0%$697.94+24.4%+59.9%$34.25B$2.19B-637.39650Positive NewsGap UpHigh Trading VolumeBNTXBioNTech2.803 of 5 stars$97.27+4.9%$142.73+46.7%+10.0%$23.34B$2.75B-46.323,080Trending NewsONCBeigene2.6879 of 5 stars$233.25+0.5%$319.00+36.8%N/A$23.07B$4.18B-28.319,000SMMTSummit Therapeutics3.1745 of 5 stars$25.26+5.4%$37.40+48.1%+437.2%$18.76B$700,000.00-90.21110Positive NewsITCIIntra-Cellular Therapies0.8741 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560GMABGenmab A/S3.4305 of 5 stars$19.93+2.9%$39.17+96.5%-31.5%$12.78B$21.64B11.451,660News CoverageHigh Trading VolumeRDYDr. Reddy's Laboratories2.3333 of 5 stars$13.93+3.9%$17.00+22.1%+5.3%$11.62B$311.31B22.1724,800Positive NewsGap UpVTRSViatris2.0723 of 5 stars$8.96+2.2%$10.50+17.2%-19.8%$10.63B$14.33B-12.1137,000Trending News Related Companies and Tools Related Companies GSK Alternatives TAK Alternatives ARGX Alternatives BNTX Alternatives ONC Alternatives SMMT Alternatives ITCI Alternatives GMAB Alternatives RDY Alternatives VTRS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TEVA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TEVA Stock Free TEVA Stock Alerts